BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18025276)

  • 1. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.
    McAllister SD; Christian RT; Horowitz MP; Garcia A; Desprez PY
    Mol Cancer Ther; 2007 Nov; 6(11):2921-7. PubMed ID: 18025276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.
    McAllister SD; Murase R; Christian RT; Lau D; Zielinski AJ; Allison J; Almanza C; Pakdel A; Lee J; Limbad C; Liu Y; Debs RJ; Moore DH; Desprez PY
    Breast Cancer Res Treat; 2011 Aug; 129(1):37-47. PubMed ID: 20859676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
    Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
    Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.
    Murase R; Sumida T; Kawamura R; Onishi-Ishikawa A; Hamakawa H; McAllister SD; Desprez PY
    Cancer Lett; 2016 Jul; 377(1):11-6. PubMed ID: 27087608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.
    Fong S; Itahana Y; Sumida T; Singh J; Coppe JP; Liu Y; Richards PC; Bennington JL; Lee NM; Debs RJ; Desprez PY
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13543-8. PubMed ID: 14578451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
    Singh J; Murata K; Itahana Y; Desprez PY
    Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells.
    Yasmeen A; Bismar TA; Kandouz M; Foulkes WD; Desprez PY; Al Moustafa AE
    Cell Cycle; 2007 Aug; 6(16):2038-42. PubMed ID: 17721085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
    Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
    Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of As
    Zhu Y; Chen W; Guan W; Fang Y; Hao C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1932-1937. PubMed ID: 31079498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
    Itahana Y; Singh J; Sumida T; Coppe JP; Parrinello S; Bennington JL; Desprez PY
    Cancer Res; 2003 Nov; 63(21):7098-105. PubMed ID: 14612502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.
    Murase R; Kawamura R; Singer E; Pakdel A; Sarma P; Judkins J; Elwakeel E; Dayal S; Martinez-Martinez E; Amere M; Gujjar R; Mahadevan A; Desprez PY; McAllister SD
    Br J Pharmacol; 2014 Oct; 171(19):4464-77. PubMed ID: 24910342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins.
    Desprez PY; Murase R; Limbad C; Woo RWL; Adrados I; Weitenthaler K; Soroceanu L; Salomonis N; McAllister SD
    Cannabis Cannabinoid Res; 2021 Apr; 6(2):148-155. PubMed ID: 33912679
    [No Abstract]   [Full Text] [Related]  

  • 16. Melatonin inhibits breast cancer cell invasion through modulating DJ-1/KLF17/ID-1 signaling pathway.
    El-Sokkary GH; Ismail IA; Saber SH
    J Cell Biochem; 2019 Mar; 120(3):3945-3957. PubMed ID: 30260001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
    Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
    Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas.
    Sharma A; Kumar A; Li C; Panwar Hazari P; Mahajan SD; Aalinkeel R; Sharma RK; Swihart MT
    J Mater Chem B; 2021 Mar; 9(10):2505-2514. PubMed ID: 33657198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
    Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
    Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.